1. Home
  2. A vs KVUE Comparison

A vs KVUE Comparison

Compare A & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$118.07

Market Cap

39.8B

Sector

Industrials

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.71

Market Cap

33.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
A
KVUE
Founded
1999
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Specialty Chemicals
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
39.8B
33.7B
IPO Year
1999
2023

Fundamental Metrics

Financial Performance
Metric
A
KVUE
Price
$118.07
$17.71
Analyst Decision
Strong Buy
Buy
Analyst Count
15
11
Target Price
$161.47
$19.45
AVG Volume (30 Days)
1.5M
14.9M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
0.92%
4.82%
EPS Growth
3.16
40.74
EPS
1.07
0.76
Revenue
$4,472,000,000.00
$15,124,000,000.00
Revenue This Year
$8.45
$4.85
Revenue Next Year
$6.13
$2.63
P/E Ratio
$109.82
$22.89
Revenue Growth
6.43
N/A
52 Week Low
$106.55
$14.02
52 Week High
$160.27
$25.17

Technical Indicators

Market Signals
Indicator
A
KVUE
Relative Strength Index (RSI) 53.49 55.21
Support Level $115.76 $17.20
Resistance Level $130.54 $17.75
Average True Range (ATR) 3.32 0.32
MACD 0.01 0.03
Stochastic Oscillator 54.75 84.76

Price Performance

Historical Comparison
A
KVUE

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: